| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9345942 | Journal Français d'Ophtalmologie | 2005 | 7 Pages |
Abstract
In treating ocular toxoplasmosis, clindamycin appears to be a safe and effective substitute for the classic protocol (pyrimethamine-sulfadiazine, pyrimethamine-azithromycin), for which a 50% recurrence rate has been reported. It provides relatively good protection against recurrence and warrants testing in further controlled studies.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Z. Benzina, S. Chaabouni, N. Hentati, A. Trigui, F. Chaabouni, S. Ben Salah, H. Khlif, J. Feki,